MCL1 and chronic myelogenous leukemia, BCR-ABL1 positive: This newly discovered drug-gene-disease correlation in the current study suggests that aspirin may be able to partially prevent ONFH secondary to CML by suppressing MCL1, and indicates a novel use of the traditional drug.